Metfendrazine

Metfendrazine (developmental code names HM-11, MO-482), also known as methphendrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine family.^[1][2] It was investigated as an antidepressant, but was never marketed.

Metfendrazine

Clinical data
Other names	Methphendrazine; HM-11; MO-482; N-Aminomethamphetamine; Methamphetamine hydrazide; N-Amino-N-methylamphetamine
Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: uncontrolled
Identifiers
IUPAC name 1-methyl-1-(1-methyl-2-phenyl-ethyl)hydrazine
CAS Number	3734-26-7 Y
PubChem CID	19516
ChemSpider	18390
UNII	A52QTC656T
CompTox Dashboard (EPA)	DTXSID701257364
Chemical and physical data
Formula	C10H16N2
Molar mass	164.252 g·mol−1

Chemistry

Metfendrazine, also known as methamphetamine hydrazide, is a phenethylamine, amphetamine, and hydrazine derivative.

It is an analogue and derivative of phenelzine (phenethylamine hydrazide) and pheniprazine (amphetamine hydrazide), as well as of phenethylamine, amphetamine, and methamphetamine.